Bank of New York Mellon Corp. (0HLQ)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 143.08 |
|---|---|
| 52-week range | 101.38 – 170.00 |
| Return, 1 month / 3 months | −6.2% / −8.8% |
| Return, 1 year / 3 years | +39.0% / +263.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 42 |
| Volatility (1 year) | 23.2% |
| Worst drawdown (1 year) | -18.3% |
| Average daily value traded | 0.47M USD |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bank of New York Mellon is a financial services company based in New York that provides custody, asset servicing and investment management to institutions, corporations and investment funds. It safeguards securities, settles trades, administers funds and offers related banking and treasury services, and its investment management arm runs money for institutional and individual clients. Its customers include pension funds, asset managers, banks and other large organisations around the world.
On this site Bank of New York Mellon Corp. appears as a stock on the London Exchange (UK), code 0HLQ, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bank of New York Mellon Corp. (0HLQ) trades on the London Exchange in UK. It last closed at USD 143.08 on 19 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 902 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 39.0% and over the last three months it fell 8.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.2% | ||
| From 52-week high | -13.6% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -8.8% | ||
| 6-month return | 7.0% | ||
| 12-month return, skipping the last month | 48.2% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.3% | ||
| Liquidity | 45 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.47M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.1% |
|---|---|
| 1 month | −6.2% |
| 3 months | −8.8% |
| 6 months | +7.0% |
| 1 year | +39.0% |
| 3 years | +263.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 154.24 / 137.31 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.20 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Jul 2026 | USD 0.6300 |
| 27 Apr 2026 | USD 0.5300 |
| 22 Jan 2026 | USD 0.5300 |
| 24 Oct 2025 | USD 0.5300 |
| 24 Jul 2025 | USD 0.5300 |
| 17 Apr 2025 | USD 0.4700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.